Madrigal Pharmaceuticals
MDGL
MDGL
282 hedge funds and large institutions have $7.08B invested in Madrigal Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 66 funds opening new positions, 95 increasing their positions, 77 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
10% more call options, than puts
Call options by funds: $354M | Put options by funds: $321M
10% more funds holding
Funds holding: 256 → 282 (+26)
0.81% more ownership
Funds ownership: 104.43% → 105.25% (+0.81%)
Holders
282
Holding in Top 10
10
Calls
$354M
Puts
$321M
Top Buyers
| 1 | +$115M | |
| 2 | +$50M | |
| 3 | +$44.6M | |
| 4 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
+$39.4M |
| 5 |
SL
Siren LLC
Greenwich,
Connecticut
|
+$38.9M |
Top Sellers
| 1 | -$83.2M | |
| 2 | -$44.7M | |
| 3 | -$39.4M | |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
-$39M |
| 5 |
State Street
Boston,
Massachusetts
|
-$32.9M |